Tsvetelina P. Hoang

VP, Research and Development, Marker Therapeutics, Inc.

Companies

Marker Therapeutics, Inc.VP, Research and Development Dec 28, 2018 to Mar 1, 2023¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMarker Therapeutics, Inc., VP, Research and Development